000 01510 a2200373 4500
005 20250515222303.0
264 0 _c20100526
008 201005s 0 0 eng d
022 _a0033-3549
024 7 _a10.1177/003335491012500319
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavid, Stephanie
245 0 0 _aWyeth v Levine: implications for public health policy and practice.
_h[electronic resource]
260 _bPublic health reports (Washington, D.C. : 1974)
_c
300 _a494-7 p.
_bdigital
500 _aPublication Type: Journal Article; Legal Case
650 0 4 _aConsumer Product Safety
_xlegislation & jurisprudence
650 0 4 _aDrug Industry
_xlegislation & jurisprudence
650 0 4 _aDrug Labeling
_xlegislation & jurisprudence
650 0 4 _aDrug and Narcotic Control
_xlegislation & jurisprudence
650 0 4 _aGangrene
_xchemically induced
650 0 4 _aHistamine H1 Antagonists
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
_xadverse effects
650 0 4 _aLiability, Legal
650 0 4 _aPromethazine
_xadministration & dosage
650 0 4 _aSupreme Court Decisions
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
_xlegislation & jurisprudence
650 0 4 _aVermont
700 1 _aRosenbaum, Sara
773 0 _tPublic health reports (Washington, D.C. : 1974)
_gvol. 125
_gno. 3
_gp. 494-7
856 4 0 _uhttps://doi.org/10.1177/003335491012500319
_zAvailable from publisher's website
999 _c19789550
_d19789550